Susceptibility testing of Pseudomonas aeruginosa by the Vitek 2 system: a comparison with Etest results
| Autor: | Pierrette Melin, Veroniek Saegeman, J. Colaert, Jan Verhaegen, Pascale Huynen |
|---|---|
| Rok vydání: | 2005 |
| Předmět: |
medicine.medical_specialty
Cefepime Ceftazidime Microbial Sensitivity Tests Meropenem Tazobactam Sensitivity and Specificity Microbiology Pseudomonas infection Internal medicine polycyclic compounds medicine Humans Etest Bacteriological Techniques business.industry General Medicine biochemical phenomena metabolism and nutrition bacterial infections and mycoses medicine.disease Amikacin Pseudomonas aeruginosa bacteria Reagent Kits Diagnostic business medicine.drug Piperacillin |
| Zdroj: | Scopus-Elsevier |
| ISSN: | 1784-3286 |
| Popis: | P. aeruginona infections need accurate antimicrobial susceptibility data, as treatment mainly relies on antibiotic efficiency in debilitated patients. Vitek 2, a popular automated susceptibility testing method, was compared with Etest to assess its reliability on 150 Belgian P. aeruginonas isolates. Vitek 2 and Etest exhibited a high degree of concordance, but some discrepancies in clinical category were evident for cefepime (high minor and borderline very major error rate) and for piperacillin/tazobactam (high very major error rate). Vitek 2 appears to yield valuable information to the clinician concerning the antimicrobials amikacin, ceftazidime, ciprofloxacin and meropenem, in the setting of pseudomonas infection. For cefepime and piperacillin/tazobactam, a confirmatory testing by means of disk diffusion is worth considering. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|